12 drug(s) with this reaction
47,580 total reports
Death has been reported as an adverse reaction across 12 drug(s) manufactured by Amgen Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 47,580 adverse event reports mention death in connection with Amgen Inc products.
This page provides a breakdown of which Amgen Inc drugs are most commonly associated with death, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Amgen Inc drugs have death listed in their FDA adverse event reports, sorted by report count:
In addition to death, the following adverse reactions have been reported across Amgen Inc's drug portfolio:
12 drug(s) manufactured by Amgen Inc have death listed in their FDA adverse event reports: DENOSUMAB, DARBEPOETIN ALFA, PEGFILGRASTIM, FILGRASTIM, CINACALCET HYDROCHLORIDE, and others.
There are a combined 47,580 reports of death across 12 Amgen Inc drug(s) in the FDA adverse event database.